 Home > Encyclopedia > 2,3-Dimethylanthracene

2,3-Dimethylanthracene

2,3-Dimethylanthracene structure

CAS No:
613-06-9
Formula:
C16H14
Chemical Name:
2,3-Dimethylanthracene
Synonyms:
Anthracene,2,3-dimethyl-;2,3-Dimethylanthracene
Categories:
Pharmaceutical Intermediates > Bulk Drug Intermediates

Request for Quotation

2,3-Dimethylanthracene Basic Attributes

Molecular Weight：

206.288

Exact Mass：

206.28

EC Number：

210-328-8

DSSTox ID：

DTXSID20210189

HScode：

2902909090

Characteristics

PSA：

XLogP3：

4.60980

Density：

1.084g/cm3

Melting Point：

252 °C

Boiling Point：

374ºC at 760 mmHg

Flash Point：

170.9ºC

Refractive Index：

1.676

Collision Cross Section：

144.4 Å² [M+H]+

Safety Information

Precautionary statement(s)：

P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P362, P403+P233, P405, P501

Hazard Statements：

H315

GHS Classification：

|Danger|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Computed Properties

Molecular Weight:206.28
XLogP3:4.9
Exact Mass:206.109550447
Monoisotopic Mass:206.109550447
Heavy Atom Count:16
Complexity:218
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 2,3-Dimethylanthracene

Shaanxi Kaierkai Pharmaceutical Technolo Contact Supplier

CN
3 YRS

Business licensed

Trader Supplier of 1,9-DIAMINONONANE,3-BUTYLPYRIDINE,1,3,5-Tris(trifluoromethyl)benzene,3-N-PROPYLPHENOL,Meclofenamic acid,4-Pentyloxyphenol,GERANIC ACID,gidazepam,2-(4-ethylbenzoyl)benzoic acid,METHYL 3-OXOTETRADECANOATE,1,5-DIMETHYL-2-PYRROLIDINONE,Tetradecanoic acid,3-[(1-oxotetradecyl)oxy]-,(R)-,1-OCTANESULFONYL CHLORIDE,3-Hydroxy Myristic Acid Methyl Ester

2,3-DIMETHYLANTHRACENE KRK

CAS No.: 613-06-9

Inquiry